Portal vein resection during pancreatectomy for pancreatic head adenocarcinoma. Scope of current opinions and own experiences.
نویسندگان
چکیده
* Authors’ results were presented at the 66th Congress of Polish Surgeons Society in Warsaw (2013) According to expert consensus, cases with distal metastases, radiographic evidence of superior mesenteric vein (SMV) and portal vein abutment, distortion, tumor thrombus or venous encasement or no clear fat plane around the celiac axis, hepatic artery and superior mesenteric artery (SMA) are not treated as resectable (1). Some tumors can be treated as borderline resectable (1). Cancer infiltrating arteries is suspected to spread through nerve plexuses and lymphatic tissue surrounding those vessels which gives positive margins of resections. That fact limits oncological radicality of procedures which involve arterial resection (2-4). In contrast, portal vein confluence is not surrounded by perivascular neural plexuses and lyphatic tissue. Involvement of the portal vein, such as tumor abutment with or without impingement, narrowing of the lumen, encasement or thrombus with a patent lumen, encasement or thrombus with patent lumen, does not impede the achievement of a R0, oncologically radical resection (1, 4). Also some selected cases of arterial involvement are bordeline resectable (gastroduodenal artery encasement up to the hepatic artery with either short segment encasement or direct abutment of hepatic artery, without extension to the celiac axis, and cases of SMA abutment not exceed >180 of the circumference of the vessel wall) (1). Surgical Technique
منابع مشابه
Managing unsuspected tumour invasion of the superior mesenteric-portal vein during surgery for pancreatic head cancer. A case report.
CONTEXT In some cases, synchronous superior mesenteric-portal vein resection can be performed during pancreatic resection for cancer. The reconstruction technique is usually primary anastomosis; in only a few cases is an autologous vein graft needed. CASE REPORT We report a case of reconstruction of the superior mesenteric-portal vein with a splenic vein autograft in a patient affected by pan...
متن کاملLong-term survival following total pancreatectomy and superior mesenteric-portal vein resection for pancreatic ductal adenocarcinoma: A case report
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with few therapeutic options. At present, surgical resection remains the only potential curative treatment for PDAC. However, only 15-20% of patients with PDAC are eligible for lesion resection. Total pancreatectomy (TP) and superior mesenteric-portal vein resection (SMPVR) may increase the rate of resection of PDCA, but the effect...
متن کاملOutcomes from mesenteric-portal axis resection during pancreatectomy
BACKGROUND Due to their complexity and risks, mesenteric-portal axis resection and reconstruction during the pancreatectomy procedure were not recommended back in the early nineties. However, as per technical improvements and the reduction in morbidity and mortality rates, they have been routinely indicated in large medical centers. AIM To show results from cases of patients subjected to mese...
متن کاملDistal pancreatectomy with splenorenal shunt to preserve spleen in a cirrhotic patient
At pancreatic ductal adenocarcinoma is an aggressive malignancy with a high recurrence rate. Due to its high potentials of local invasion and distant metastasis, surgical resection is the only means for possible long-term survival. Surgical treatment comprises a distal pancreatectomy with or without splenectomy. Surgery has been conventionally contraindicated for patients with cirrhosis and por...
متن کاملCurative resection of pancreatic adenocarcinoma with major venous resection/repair is safe procedure but will not improve survival.
OBJECTIVE To evaluate the safety and survival benefit of combined curative resection (CR) of the pancreas and major venous resection in the management of borderline resectable pancreatic adenocarcinoma. METHODS In this IRB approved retrospective cohort study, patients who had pancreatic surgery (n=274) between 1998-2012 were reviewed. One hundred and seventy-five patients had malignant causes...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Polski przeglad chirurgiczny
دوره 86 7 شماره
صفحات -
تاریخ انتشار 2014